Providing credible, evidence-based information about medical technologies, treatments, and models of care
Attend a Meeting
CTAF will assess the comparative effectiveness and value of multiple new, all-oral direct-acting antiviral agent (DAA) regimens for the treatment of hepatitis C.
Sign up to receive email notifications of upcoming CTAF meetings and new assessments. All fields required.